The debate centers on Sellas’ Phase 3 Regal trial, which is testing its immunotherapy Galinpepimut-S (GPS) as a maintenance ...

How could relapse in leukemia after CAR T treatment—a problem that still affects between 30–60% of patients—be prevented? One major driver is antigen escape: leukemia cells can dial down or lose the ...

ROANOKE, Va. (WDBJ) - A Roanoke-based nonprofit founded in memory of a young woman diagnosed with a rare form of leukemia is marking seven years of service to young adults facing cancer treatment.

Chimeric antigen receptor T (CAR T) cell therapy represents a milestone in leukemia treatment. CAR T works by genetically engineering a chimeric antigen receptor on the surface of the patient's T ...

Dr. Hope Rugo explains how antibody-drug conjugates like Datroway and Trodelvy are shifting the treatment landscape for ...

Chimeric antigen receptor T (CAR T) cell therapy represents a milestone in leukemia treatment. CAR T works by genetically ...

Treatments for Alzheimer disease agitation, focal segmental glomerulosclerosis, hematological malignancies, HIV-1, and obesity are under review.

New ASH guidelines outline optimal management for a subgroup of patients with leukemia that historically has been challenging to treat.Two papers published simultaneously in Blood Advances address ...

Cancer researchers including senior author Christopher Hourigan (at left) and first author Rasha Al-Ali of Virginia Tech’s Fralin Biomedical Research Institute found that a highly sensitive DNA-based ...

Debi Weiss was annoyed but not concerned when she started feeling weak and out of breath in January 2024. She thought it was ...

A Falls Church City family’s battle with leukemia and a daughter’s determination to help others facing the disease will be at ...